Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ORCL vs CVS✓SelectedUSD · CVSORCL vs CVS performance historyLatest closeAs of-3.43%11/17
Stock and ETF performance explorer

ORCL vs CVS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+231.7%
CVS return
+57.5%
Excess return
+174.2%
Maximum drawdown
-64.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCVSExcessAlpha
1D-3.4%-3.1%-0.3%-2.8%
7D-2.5%-3.6%+1.1%-1.7%
30D-10.3%-6.4%-3.9%-9.2%
3M-21.3%-8.1%-13.2%-20.2%
6M-40.0%-9.3%-30.7%-39.3%
YTD-40.2%+11.4%-51.7%-43.1%
1Y-47.0%+12.8%-59.8%-49.8%
3Y+3.3%+39.6%-36.4%-10.4%
5Y+29.1%+9.4%+19.7%+20.8%
10Y+231.7%+57.7%+174.0%+153.4%
All+231.7%+57.5%+174.2%+153.4%

Cumulative growth

Daily Returns

Daily percentage return beside CVS.

Daily Out/Under-Performance

Portfolio return minus CVS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling